Literature DB >> 31527174

Off-Label Prescribing in Children Remains High: A Call for Prioritized Research.

Katelyn Yackey1, Rachel Stanley2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31527174     DOI： 10.1542/peds.2019-1571

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  2 in total

Review 1.  Phase 0/microdosing approaches: time for mainstream application in drug development?

Authors:  Tal Burt; Graeme Young; Wooin Lee; Hiroyuki Kusuhara; Oliver Langer; Malcolm Rowland; Yuichi Sugiyama
Journal:  Nat Rev Drug Discov       Date:  2020-09-08       Impact factor: 84.694

2.  A Sponsor's View on Postmarketing Regulatory Commitments Involving Human Drug Products.

Authors:  Laura McKinley; Milton L Pressler; Mary A Hiatt; William Gregory
Journal:  Clin Pharmacol Ther       Date:  2021-07-12       Impact factor: 6.903
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.